Henry Schein Inc - HSIC STOCK NEWS

Henry Schein (HSIC) has completed the acquisition of substantially all assets of Acentus, a national medical supplier specializing in Continuous Glucose Monitors (CGMs). The deal, initially announced on November 20, 2024, brings Acentus founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia into Henry Schein's team, incorporating their healthcare industry and product expertise.

The transaction was facilitated by Provident Healthcare Partners, with their deal team led by Managing Director Kevin Palamara. Robinson & Cole provided legal counsel to Acentus during the acquisition process. Acentus has developed a distinctive CGM platform that has shown significant growth since its establishment.

Henry Schein (Nasdaq: HSIC) has completed the acquisition of Acentus, a Tampa-based national medical supplier specializing in Continuous Glucose Monitors (CGMs) with annual revenue of approximately $35 million. The transaction is expected to be neutral to 2025 non-GAAP earnings per share and accretive thereafter.

This acquisition follows Henry Schein's previous acquisitions of Prism Medical Products (2021), Shield Healthcare, and Mini Pharmacy (2023), strengthening its position in the homecare medical supplies market. With the addition of Acentus, Henry Schein's homecare medical products platform will now have an annual revenue base exceeding $350 million.

The four Acentus founders will join Henry Schein, bringing their expertise in the product category and healthcare industry. The acquisition aims to enhance Henry Schein's ability to serve customers through direct CGM product delivery to patients' homes.

Henry Schein (Nasdaq: HSIC) has announced the opening of the Henry Schein Cares Foundation 2025 Relief Fund to support Los Angeles area fires relief efforts. The initiative includes a total commitment of up to $300,000, comprising:

- $25,000 each from the Company and Foundation
- Up to $50,000 in matching Team Schein Member contributions
- Up to $150,000 in essential healthcare supplies

The company has established a Customer Emergency Support Hotline (800-999-9729) for affected dental and medical professionals. The initiative aims to provide critical healthcare supplies and resources to communities impacted by the wildfires, working with trusted relief and recovery charitable partners.

Henry Schein (NASDAQ: HSIC) has activated its Customer Emergency Support Hotline at 800-999-9729 to assist dental and medical professionals affected by the ongoing California fires. The hotline provides 24/7 support, with live assistance from Team Schein Members available from 8 a.m. to 8 p.m. Eastern Time.

The company offers resources to help practitioners manage operational, logistical, and financial challenges resulting from the natural disaster. These include an Emergency Preparedness Guide to minimize disaster impact and an Emergency Recovery Guide to assist in practice rebuilding efforts.

Henry Schein (HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its participation in J.P. Morgan's Healthcare Investor Conference. The presentation is scheduled for Tuesday, January 14, 2025, at 3:00 p.m. PST / 6:00 p.m. EST at The Westin St. Francis Hotel in San Francisco. Investors and interested parties can access the live webcast through www.henryschein.com/IRwebcasts, with replay options available on the company's website after the presentation.

Henry Schein (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its participation in two major investor conferences this December. The company will present at Piper Sandler's Healthcare Conference in New York on December 4, 2024, at 11:00 a.m. Eastern time, and at the Evercore ISI HealthCONx Conference in Coral Gables, Florida, on December 5, 2024, at 9:10 a.m. Eastern time. Both presentations will be available via live webcast on the company's website, with replays accessible afterward.

Henry Schein (NASDAQ: HSIC) has signed an agreement to acquire Acentus, a national medical supplier specializing in Continuous Glucose Monitors (CGMs) with annual revenue of $35 million. This acquisition follows Henry Schein's previous acquisitions of Prism Medical Products, Shield Healthcare, and Mini Pharmacy, expanding their homecare medical products platform to an annual revenue base of approximately $350 million. The transaction is expected to be neutral to 2024 non-GAAP earnings per share, accretive thereafter, and close in Q1 2025. Acentus's founders will join Henry Schein post-acquisition.

Henry Schein (HSIC) reported Q3 2024 financial results with total net sales of $3.2 billion, up 0.4% from Q3 2023. The company achieved GAAP EPS of $0.78 and non-GAAP EPS of $1.22. Operating cash flow was $151 million for Q3, with year-to-date cash flow of $644 million. The company increased its 2024 full-year non-GAAP EPS guidance to $4.74-$4.82 from $4.70-$4.82. During Q3, Henry Schein repurchased approximately 2.0 million shares at an average price of $69.09 per share, totaling $135 million.

Henry Schein (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has announced its participation in two major investor conferences this November. The company will present at Stifel's Healthcare Conference in New York on November 18, 2024, at 9:45 a.m. EST, and at the Jefferies London Healthcare Conference on November 19, 2024, at 1:30 p.m. GMT/8:30 a.m. EST. Both presentations will be available via live webcast on the company's website, with replays accessible afterward.